Clinical Trial Update: Study of the Imaging Agent 18F-Var3 in Patients With Breast Cancer [Phase 1]

View source ↗

Summary

This update summarizes a Phase 1 trial of the imaging agent 18F-Var3 in patients with breast cancer, which has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 18F-Var3

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED